DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • South Korea
  • /
  • Healthcare
Author Program NEWCreate Narrative
A303360 logo

Protia Inc. Stock Price

KOSDAQ:A303360 Community·₩66.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

A303360 Share Price Performance

₩5,180.00
-760.00 (-12.79%)
​
₩5,180.00
-760.00 (-12.79%)
​
Price ₩5,180.00
Fri, 11 Sep 26
Share Pricen/a

A303360 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

2 Risks
1 Reward
View Full Analysis

Protia Inc. Key Details

₩17.7b

Revenue

₩6.8b

Cost of Revenue

₩10.9b

Gross Profit

₩5.4b

Other Expenses

₩5.5b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
426.94
61.46%
30.98%
0%
View Full Analysis

About A303360

Founded
2000
Employees
n/a
CEO
Kook Jin Lim
WebsiteView website
www.protia.co.kr

Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Recent A303360 News & Updates

Analysis Article • May 21

Protia's (KOSDAQ:303360) Promising Earnings May Rest On Soft Foundations

Despite posting some strong earnings, the market for Protia Inc.'s ( KOSDAQ:303360 ) stock hasn't moved much. Our...

Recent updates

No updates

Protia Inc. Competitors

A028300 logo

HLB

Symbol: KOSDAQ:A028300
Market cap: ₩4.2t
A008930 logo

Hanmi Science

Symbol: KOSE:A008930
Market cap: ₩3.7t
A214150 logo

CLASSYS

Symbol: KOSDAQ:A214150
Market cap: ₩2.0t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide